- Home
- Publications
- Publication Search
- Publication Details
Title
Blood Stream Infections from MDR Bacteria
Authors
Keywords
-
Journal
Life-Basel
Volume 11, Issue 6, Pages 575
Publisher
MDPI AG
Online
2021-06-18
DOI
10.3390/life11060575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftolozane-Tazobactam Combination Therapy Compared to Ceftolozane-Tazobactam Monotherapy for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
- (2021) Marco Fiore et al. Antibiotics-Basel
- Bloodstream infections in critically ill patients: an expert statement
- (2020) Jean-François Timsit et al. INTENSIVE CARE MEDICINE
- Bloodstream infections in critically ill patients with COVID‐19
- (2020) Daniele Roberto Giacobbe et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: Impact of MDR and XDR bacteria
- (2020) Antonella Santoro et al. Open Forum Infectious Diseases
- Diagnostic stewardship for sepsis: the need for risk stratification to triage patients for fast microbiology workflows
- (2019) Davide Mangioni et al. Future Microbiology
- Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
- (2019) Timothy A. Blauwkamp et al. Nature Microbiology
- Clinical metagenomics
- (2019) Charles Y. Chiu et al. NATURE REVIEWS GENETICS
- De-escalation of antimicrobial therapy in critically ill hematology patients: a prospective cohort study
- (2019) David Schnell et al. INTENSIVE CARE MEDICINE
- Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections
- (2019) M. Hong Nguyen et al. ANNALS OF INTERNAL MEDICINE
- The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program
- (2019) Daniel J. Diekema et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study
- (2019) Evelina Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection
- (2019) Maya Beganovic et al. Open Forum Infectious Diseases
- Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis
- (2019) Matthew P. Cheng et al. ANNALS OF INTERNAL MEDICINE
- Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)
- (2019) Alexis Tabah et al. INTENSIVE CARE MEDICINE
- Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial
- (2018) Philippe Montravers et al. INTENSIVE CARE MEDICINE
- Bloodstream infections in cancer patients. Risk factors associated with mortality
- (2018) Beda Islas-Muñoz et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
- (2018) Matteo Bassetti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenems and alternative beta-lactams for the treatment of infections due to ESBL-producing Enterobacteriaceae: what impact on intestinal colonization resistance?
- (2018) Paul-Louis Woerther et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria
- (2018) Daniele Roberto Giacobbe et al. Expert Review of Clinical Pharmacology
- Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance
- (2017) Jan J. De Waele et al. INTENSIVE CARE MEDICINE
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy
- (2017) Christophe Adrie et al. JOURNAL OF INFECTION
- De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition
- (2016) E. Weiss et al. INTENSIVE CARE MEDICINE
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bloodstream infections in the Intensive Care Unit
- (2016) Matteo Bassetti et al. Virulence
- Next-generation sequencing diagnostics of bacteremia in septic patients
- (2016) Silke Grumaz et al. Genome Medicine
- A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients
- (2015) Mieke Carlier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
- (2014) Kevin B. Laupland et al. CLINICAL MICROBIOLOGY REVIEWS
- De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
- (2014) Marc Leone et al. INTENSIVE CARE MEDICINE
- Epidemiology and outcomes of bloodstream infection in patients with cirrhosis
- (2014) Michele Bartoletti et al. JOURNAL OF HEPATOLOGY
- Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
- (2013) Laurence Armand-Lefèvre et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ribosome-targeting antibiotics and mechanisms of bacterial resistance
- (2013) Daniel N. Wilson NATURE REVIEWS MICROBIOLOGY
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
- (2012) Alexis Tabah et al. INTENSIVE CARE MEDICINE
- Early Dissemination of NDM-1- and OXA-181-ProducingEnterobacteriaceaein Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
- (2010) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China
- (2010) Dejing Wu et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC)
- (2010) A. Corona et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bloodstream Infection After Kidney Transplantation: Epidemiology, Microbiology, Associated Risk Factors, and Outcome
- (2010) Moacyr Silva et al. TRANSPLANTATION
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Waves of resistance: Staphylococcus aureus in the antibiotic era
- (2009) Henry F. Chambers et al. NATURE REVIEWS MICROBIOLOGY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
- (2008) R. Hope et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started